Talk on ‘Butt Cancer’ Tackles Taboo with Humor to Win 2018 Postdoc Slam
Ten UCSF postdocs competed to explain complex research in simple language – and in three minutes or less – in the third annual Postdoc Slam held Sept. 26.
University of California San Francisco
Give to UCSF
Displaying 301 - 330 of 1072
-
-
Six UCSF Scientists Awarded NIH Grants for High-Risk, High-Reward Research
The National Institutes of Health has awarded six NIH Director’s Awards to early-career UCSF scientists – a record number for the University.
-
Present at Creation of Nobel-Winning ‘Checkpoint Inhibitor’ Therapies, Immunologist Looks to the Future
UCSF’s Max Krummel was a graduate student in the laboratory of Nobel Prize winner James P. Allison, PhD. Now Krummel is leading an ambitious project at UCSF to expand immunology and immunotherapy to understand and potentially treat new diseases.
-
UCSF Health and John Muir Health to Build East Bay Cancer Network
UCSF Health and John Muir Health signed a letter of intent to develop a cancer network designed to improve prevention, diagnosis and treatment for patients throughout the East Bay.
-
UCSF Receives $20 Million to Study New Tobacco Products
UCSF has been awarded a five-year, $20 million grant from the U.S. Food and Drug Administration and the National Institutes of Health to study the impacts of new and emerging tobacco products.
-
HPV and Tobacco Induce Cancer Through Common Pathways
These results confirm that the HPV virus causes head and neck cancer by inactivating the same proteins that are mutated in smoking-induced cancer.
-
Researchers Unlock Secret of Deadly Brain Cancer’s “Immortality”
UCSF researchers have discovered how a mutation in a gene regulator called the TERT promoter confers “immortality” on tumor cells, enabling the unchecked cell division that powers their aggressive growth.
-
Mutations, Drugs Drive Cancer by Blurring Growth Signals
Genetic mutations in a form of non–small cell lung cancer may drive tumor formation by blurring cells’ perception of key growth signals, according to a new laboratory study published Aug. 31, 2018, in Science.
-
UCSF Benioff Children’s Hospitals will ‘Be Gold’ in September for Pediatric Cancer Awareness
UCSF Benioff Children’s Hospitals are part of a nationwide campaign to shine a spotlight on childhood cancer during Pediatric Cancer Awareness Month in September—with the color gold as the campaign’s symbol.
-
Tailored Drug Cocktails Offer Hope to Kids with Aggressive Brain Tumors
By creating a tailored drug cocktail that matches the mutations of a brain tumor, a new precision medicine approach may move the needle for children with high-grade gliomas.
-
Breast Cancer Surgery in Frail Elderly Women Linked to Poor Results
UCSF researchers found that 58 percent of women who resided in a nursing home for more than 90 days before breast cancer surgery experienced significant functional decline one year after surgery.
-
Chronic Inflammation Can Trigger Cancers Via Newly Discovered Mechanism
In these patients, chronic tissue inflammation causes an over-active protein to introduce mutations across the genome, some of which eventually lead to cancer.
-
Risk of Heart Attacks is Double for Daily E-Cigarette Users
Use of e-cigarettes every day can nearly double the odds of a heart attack, according to a new analysis of a survey of nearly 70,000 people, led by researchers at UCSF.
-
UCSF Medical Center Is Best Hospital in California for 2018-19
UCSF ranked sixth on the national Best Hospitals Honor Roll and received special recognition for exceptional performance in 15 medical specialties, including top-10 status in a dozen.
-
‘Undruggable’ Cancers Slowed by Targeting Growth Signals
Researchers have identified a new strategy for potentially treating a subset of intractable cancers by decoupling the entire RAS / MAP Kinase signaling pathway from external growth signals.
-
MEDIA ADVISORY: UCSF Benioff Children’s Hospital Oakland Research Institute’s (CHORI) 37th Annual Summer Student Research Program Concludes with Summer Student Symposium
Students who spent their summer doing laboratory and clinical research alongside BCHO doctors and CHORI scientists are presenting their research at a scientific symposium at CHORI on Friday, August 10.
-
Important Cancer-Tracking Registry to Locate at UCSF
The Greater Bay Area Cancer Registry, which has been at the forefront of cancer data collection throughout the region is moving its headquarters and management to UCSF.
-
Genetic Study of Familial Leukemia Solves 30-Year Medical Mystery
A decades-old medical mystery has been solved by researchers at UCSF and St. Jude Children’s Research Hospital in Tennessee, who have discovered a pair of inherited genetic mutations underlying a familial blood disorder that sometimes leads to leukemia.
-
CRISPR-Based Tool Maps Gene Function in Human Cells
UCSF scientists have used a high-throughput CRISPR-based technique to rapidly map the functions of nearly 500 genes in human cells, many of them never before studied in detail.
-
Genomic Landscape of Metastatic Prostate Cancer Unveiled in New Study
A comprehensive genetic analysis of metastatic prostate cancer has, for the first time, revealed a number of major ways in which abnormal alterations of the genome propel this aggressive form of the disease.
-
Breast Cancer Follow-Up Imaging Varies Widely, Study Finds
Follow-up imaging for women with non-metastatic breast cancer varies widely across the country, according to a new study led by researchers at UCSF.
-
Swift Gene-Editing Method May Revolutionize Treatments for Cancer and Infectious Diseases
-
T Cell Engineering Breakthrough Sidesteps Need for Viruses in CRISPR Gene-Editing
In an achievement that has significant implications for research, medicine, and industry, UCSF scientists have genetically reprogrammed human immune cells without using viruses to insert DNA
-
Deadly Form of Advanced Prostate Cancer is Common, Calls for Distinct Treatment
Study of prostate cancer in 202 men, whose cancers had spread and were resistant to standard treatment, found that about 17 percent of these cancers belong to a deadlier subtype of metastatic prostate cancer.
-
Evolution of Melanoma Reveals Opportunities for Intervention
UCSF researchers have identified the sequence of genetic changes that transform benign moles to into malignant skin cancer.
-
Aggressive, deadly type of prostate cancer occurs at higher rate than previously thought
-
Staying Safe in the Sun
Sun exposure can boost your mood, but it can also significantly boost your risk of skin cancer. Sarah Arron dispels myths around UV rays and gives you her best advice on skin protection.
-
Combination Therapy May Revive Prospects for ‘Embattled’ Breast Cancer Drugs
Researchers identified a protein that cancer cells use as a shield to protect the PI3K pathway against targeted drugs, and showed that blocking this protein allowed previously ineffective therapies to slow cancer cell growth and shrink tumors.
-
Immune Profile for Successful Cancer Immunotherapy Discovered
UCSF researchers have identified a key biological pathway in human cancer patients that appears to prime the immune system for a successful response to immunotherapy drugs – checkpoint inhibitors.
-
2018: A Drug Odyssey
The journey from discovering and developing effective, precise medications to using them correctly and safely in patients is hardly fast and easy. Nor is it a straight shot. Scientists in the UCSF School of Pharmacy are challenging the status quo every step of the way.
